1. Market Research
  2. > Plethora Solutions Holdings plc - Product Pipeline Review - 2013

Plethora Solutions Holdings plc - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 43 pages

Plethora Solutions Holdings plc - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Plethora Solutions Holdings plc - Product Pipeline Review - 2013” provides data on the Plethora Solutions Holdings plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Plethora Solutions Holdings plc’s corporate website, SEC filings, investor presentations and featured press releases, both from Plethora Solutions Holdings plc and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Plethora Solutions Holdings plc - Brief Plethora Solutions Holdings plc overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Plethora Solutions Holdings plc human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Plethora Solutions Holdings plc with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Plethora Solutions Holdings plc’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Plethora Solutions Holdings plc’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Plethora Solutions Holdings plc in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Plethora Solutions Holdings plc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Plethora Solutions Holdings plc.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Plethora Solutions Holdings plc and identify potential opportunities in those areas.

Table Of Contents

Plethora Solutions Holdings plc - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Plethora Solutions Holdings plc Snapshot 5
Plethora Solutions Holdings plc Overview 5
Key Information 5
Key Facts 5
Plethora Solutions Holdings plc - Research and Development Overview 6
Key Therapeutic Areas 6
Plethora Solutions Holdings plc - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
Plethora Solutions Holdings plc - Pipeline Products Glance 13
Plethora Solutions Holdings plc - Late Stage Pipeline Products 13
Pre-Registration Products/Combination Treatment Modalities 13
Phase III Products/Combination Treatment Modalities 14
Plethora Solutions Holdings plc - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Plethora Solutions Holdings plc - Drug Profiles 16
(lidocaine + prilocaine) 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
(aviptadil + phentolamine mesylate) 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
(lidocaine + sodium bicarbonate) 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
TUC-202 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
TUC-203 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
TUC-204 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
phenylephrine 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
PSD-506 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
Plethora Solutions Holdings plc - Pipeline Analysis 28
Plethora Solutions Holdings plc - Pipeline Products by Therapeutic Class 28
Plethora Solutions Holdings plc - Pipeline Products by Target 30
Plethora Solutions Holdings plc - Pipeline Products by Route of Administration 32
Plethora Solutions Holdings plc - Pipeline Products by Molecule Type 33
Plethora Solutions Holdings plc - Pipeline Products by Mechanism of Action 34
Plethora Solutions Holdings plc - Recent Pipeline Updates 36
Plethora Solutions Holdings plc - Dormant Projects 38
Plethora Solutions Holdings plc - Company Statement 39
Plethora Solutions Holdings plc - Locations And Subsidiaries 41
Head Office 41
Other Locations and Subsidiaries 41
Appendix 42
Methodology 42
Coverage 42
Secondary Research 42
Primary Research 42
Expert Panel Validation 42
Contact Us 43
Disclaimer 43



List of Tables

Plethora Solutions Holdings plc, Key Information 5
Plethora Solutions Holdings plc, Key Facts 5
Plethora Solutions Holdings plc - Pipeline by Indication, 2013 7
Plethora Solutions Holdings plc - Pipeline by Stage of Development, 2013 8
Plethora Solutions Holdings plc - Monotherapy Products in Pipeline, 2013 9
Plethora Solutions Holdings plc - Combination Treatment Modalities in Pipeline, 2013 10
Plethora Solutions Holdings plc - Partnered Products in Pipeline, 2013 11
Plethora Solutions Holdings plc - Partnered Products/ Combination Treatment Modalities, 2013 12
Plethora Solutions Holdings plc - Pre-Registration, 2013 13
Plethora Solutions Holdings plc - Phase III, 2013 14
Plethora Solutions Holdings plc - Phase II, 2013 15
Plethora Solutions Holdings plc - Pipeline by Therapeutic Class, 2013 29
Plethora Solutions Holdings plc - Pipeline by Target, 2013 31
Plethora Solutions Holdings plc - Pipeline by Route of Administration, 2013 32
Plethora Solutions Holdings plc - Pipeline by Molecule Type, 2013 33
Plethora Solutions Holdings plc - Pipeline Products by Mechanism of Action, 2013 35
Plethora Solutions Holdings plc - Recent Pipeline Updates, 2013 36
Plethora Solutions Holdings plc - Dormant Developmental Projects,2013 38
Plethora Solutions Holdings plc, Subsidiaries 41



List of Figures

Plethora Solutions Holdings plc - Pipeline by Top 10 Indication, 2013 7
Plethora Solutions Holdings plc - Pipeline by Stage of Development, 2013 8
Plethora Solutions Holdings plc - Monotherapy Products in Pipeline, 2013 9
Plethora Solutions Holdings plc - Combination Treatment Modalities in Pipeline, 2013 10
Plethora Solutions Holdings plc - Pipeline by Top 10 Therapeutic Class, 2013 28
Plethora Solutions Holdings plc - Pipeline by Top 10 Target, 2013 30
Plethora Solutions Holdings plc - Pipeline by Top 10 Route of Administration, 2013 32
Plethora Solutions Holdings plc - Pipeline by Top 10 Molecule Type, 2013 33
Plethora Solutions Holdings plc - Pipeline Products by Top 10 Mechanism of Action, 2013 34



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.